Fibrinolytika
Author:
Publisher
Springer Berlin Heidelberg
Link
http://link.springer.com/content/pdf/10.1007/978-3-642-18649-3_44
Reference71 articles.
1. AIMS Trial Study Group (1988) Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a plazebo controlled clinical trial. Lancet 1:545–549
2. Antman EM, Giugliano RP, Gibson M et al for the TIMI 14 Investigators (1999) Abciximab facilitates the rate and extent of thrombolysis. Results of the TIM114 trial. Circulation 99:2720–2732
3. Antithrombotic Trialists’ Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BJM 324:71–86
4. ASSENT 2 Investigators (1999) Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction. The ASSENT-2 double blind randomized trial. Lancet 354:716–722
5. Bode C, Smalling RW, Sen S et al (1993) Recombinant plasminogen activator angiographic phase II international dose finding study (RAPID): patency analysis and mortality endpoints. Circulation 88(Suppl I): 292
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3